These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17408564)

  • 1. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.
    Singh S; Dikshit M
    Brain Res Rev; 2007 Jun; 54(2):233-50. PubMed ID: 17408564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuronal death caused by apoptosis in Parkinson disease].
    Ruberg M; France-Lanord V; Brugg B; Lambeng N; Michel PP; Anglade P; Hunot S; Damier P; Faucheux B; Hirsch E; Agid Y
    Rev Neurol (Paris); 1997 Sep; 153(8-9):499-508. PubMed ID: 9683999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide in Parkinson's disease.
    Zhang L; Dawson VL; Dawson TM
    Pharmacol Ther; 2006 Jan; 109(1-2):33-41. PubMed ID: 16005074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy.
    Henshall DC
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):421-3. PubMed ID: 17371290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cell death in experimental models of Parkinson's disease.
    Hirsch EC; Hunot S; Hartmann A
    Funct Neurol; 2000; 15(4):229-37. PubMed ID: 11213526
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
    Michel PP; Ruberg M; Hirsch E
    Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacologic aspects of apoptosis: significance for neurodegenerative diseases.
    Michel PP; Lambeng N; Ruberg M
    Clin Neuropharmacol; 1999; 22(3):137-50. PubMed ID: 10367178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide has dual opposite roles during early and late phases of apoptosis in cerebellar granule neurons.
    Bobba A; Atlante A; Moro L; Calissano P; Marra E
    Apoptosis; 2007 Sep; 12(9):1597-610. PubMed ID: 17503222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does neuronal loss in Parkinson's disease involve programmed cell death?
    Andersen JK
    Bioessays; 2001 Jul; 23(7):640-6. PubMed ID: 11462217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
    Nakaso K; Ito S; Nakashima K
    Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of programmed cell death in neuronal cells by nitric oxide.
    Kang YC; Kim PK; Choi BM; Chung HT; Ha KS; Kwon YG; Kim YM
    In Vivo; 2004; 18(3):367-76. PubMed ID: 15341193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration.
    Arboleda G; Morales LC; Benítez B; Arboleda H
    Brain Res Rev; 2009 Mar; 59(2):333-46. PubMed ID: 18996148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide: NO apoptosis or turning it ON?
    Brüne B
    Cell Death Differ; 2003 Aug; 10(8):864-9. PubMed ID: 12867993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalpol attenuates nitric oxide increase via ERK signaling pathways induced by rotenone in mesencephalic neurons.
    Bi J; Jiang B; Hao S; Zhang A; Dong Y; Jiang T; An L
    Neurochem Int; 2009; 54(3-4):264-70. PubMed ID: 19111870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death in the substantia nigra: a motor tragedy.
    Esposito E; Di Matteo V; Di Giovanni G
    Expert Rev Neurother; 2007 Jun; 7(6):677-97. PubMed ID: 17563251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway.
    Guo S; Yan J; Yang T; Yang X; Bezard E; Zhao B
    Biol Psychiatry; 2007 Dec; 62(12):1353-62. PubMed ID: 17624318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
    Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
    Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease.
    Thomas T; Timmer M; Cesnulevicius K; Hitti E; Kotlyarov A; Gaestel M
    J Neurochem; 2008 Jun; 105(5):2039-52. PubMed ID: 18298661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.